e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIV
Zuur Marlanka A., Akkerman Onno W., Touw Daan J., van der Werf Tjip S., Cobelens Frank, Burger David M., Grobusch Martin P., Alffenaar Jan-Willem C.
Source:
Eur Respir J 2016; 48: 932-934
Journal Issue:
September
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Zuur Marlanka A., Akkerman Onno W., Touw Daan J., van der Werf Tjip S., Cobelens Frank, Burger David M., Grobusch Martin P., Alffenaar Jan-Willem C.. Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIV. Eur Respir J 2016; 48: 932-934
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
γδT lymphocytes in the peripheral blood of tuberculosis patients with and without HIV co-infection
Source: Eur Respir J 2001; 18: Suppl. 33, 313s
Year: 2001
Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019
Year: 2020
Recurrent tuberculosis among HIV infected persons in Singapore
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
Tuberculosis (TB) detection with HIV infected patients
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
The tuberculosis in patients with HIV and AIDS
Source: Eur Respir J 2007; 30: Suppl. 51, 656s
Year: 2007
Evaluation of IP-10 in blood serum for TB diagnosis in patients with late-stage HIV infection
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Transthyretin in patients with pulmonary tuberculosis co-infected HIV.
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Evaluation of the multidrug resistant TB in children with HIV infection
Source: Eur Respir J 2004; 24: Suppl. 48, 439s
Year: 2004
Application of therapeutic pneumoperitoneum for multi-drug resistant cavitary TB in HIV – infected patients
Source: Eur Respir J 2004; 24: Suppl. 48, 650s
Year: 2004
Multidrug-resistant TB in children with HIV infection
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Characterization of the HBHA response in TB patients with or without HIV infection.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
Response to
M. tuberculosis
selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Consideration about chemoresistant TB incidence at HIV infected children in Romania
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
Value of third sputum specimen for microscopic detection of pulmonary tuberculosis in HIV infected patients
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
The burden of childhood and adult tuberculosis, including MDR and TDR TB
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014
Tuberculosis in HIV infected patients in a large industrial center
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
The rate of tuberculosis infection in closed contacts of smear positive pulmonary tuberculosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 474s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept